THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

QUADRANT CAPITAL GROUP LLC's Holding History (CIK: 0001650717)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 335 Value ($000) $3 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 1,032 Value ($000) $10 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 226 Value ($000) $2 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 989 Value ($000) $8 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 747 Value ($000) $7 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 286 Value ($000) $3 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 52 Value ($000) $0 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 52 Value ($000) $1 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 52 Value ($000) $1 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 128 Value ($000) $1 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 135 Value ($000) $1 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 135 Value ($000) $1 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 174 Value ($000) $2 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 174 Value ($000) $2 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 37 Value ($000) $0 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 25 Value ($000) $0 Avg Close $18.78 Range $14.46 - $22.74
Q1 2020
Shares 1,693 Value ($000) $39 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 1,685 Value ($000) $43 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 1,685 Value ($000) $32 Avg Close $20.20 Range $16.00 - $24.34